HERZUMA
Manufacturing · Kansas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 7588, Overland Park, Kansas, 6620...Phone Number
(845) 348-0400Website
www.herzuma.comRevenue
$6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About HERZUMA
HERZUMA is a prescription medicine specifically designed for the treatment of early-stage and metastatic breast cancer, particularly in patients with HER2-positive tumors. It is also approved for the treatment of HER2-positive metastatic gastric cancer when used in combination with chemotherapy. The product is intended for adult patients, and its administration might include combination therapies with various chemotherapy drugs. Important safety information highlights potential serious side effects, including heart and lung complications, which healthcare providers monitor during treatment.Explore more
Popular SearchesHerzumaTeva Sales and Marketing IncSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is HERZUMA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once HERZUMA has new funding data
Earning: See what the market has to say on HERZUMA recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at HERZUMA
Product Launch: Get notified when HERZUMA launches new products
HERZUMA, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if HERZUMA had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if HERZUMA is spiking on competitors!
Check if HERZUMA has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at HERZUMA
Find more new buyers
Compare Similar Companies to HERZUMA
Compare insights from companies similar to HERZUMA, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
HERZUMA is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
HERZUMA is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about HERZUMA.
HERZUMA Tech Stack
A closer look at the technologies used by HERZUMA
HERZUMA News & Media
Teva and Celltrion Healthcare Announce U.S. Availability of HERZUMA® (trastuzumab-pkrb) for Injection
TEL AVIV, Israel & PARSIPPANY, N.J. & INCHEON, South Korea--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Celltrion Healthcare, Co., Ltd. (KRX KOSDAQ:091990), today announced that HERZUMA®1 (trastuzumab-pkrb) for Injection, a biosimilar to HERCEPTIN®1, is now available in the United States with the same indications as the reference product including: Adjuvant Breast Cancer HERZUMA is indicated for the aTeva and Celltrion Announce the Availability of TRUXIMA® (rituximab-abbs) Injection, the First Biosimilar to Rituxan® (rituximab) in the United States
JERUSALEM & PARSIPPANY, N.J. & INCHEON, South Korea--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), Celltrion, Inc., (KRX KRX:068270) and Celltrion Healthcare, Co., Ltd. (KRX KOSDAQ:091990), today announced that TRUXIMA® (rituximab-abbs) injection is the first biosimilar to the reference product Rituxan®1 (rituximab) now available in the United States with a full oncology label. TRUXIMA is currently indicate
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding HERZUMA
Sign Up For FreeTo access detailed company insights
HERZUMA is a prescription medicine specifically designed for the treatment of early-stage and metastatic breast cancer, particularly in patients with HER2-positive tumors. It is also approved for the treatment of HER2-positive metastatic gastric cancer when used in combination with chemotherapy. The product is intended for adult patients, and its a... Read More
